Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| VARIAN MEDICAL SYSTEMS INCVAR · Entity 140252 | SVP, Finance, Corp Controller | November 21, 2016 | November 22, 2016 |
| Varex Imaging CorpVREX · Entity 5135 | SVP & Chief Financial Officer | February 14, 2020 | February 19, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
VARIAN MEDICAL SYSTEMS INC
Report date November 21, 2016 · Filed November 22, 2016
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 5,576 |
Ending reported balance
After 2016-11-21 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2016-11-21 · Exercise / conversion · Acquired 1,347 · Balance 6,050 F1: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. Row 2 · 2016-11-21 · Tax withholding · Disposed 474 · Balance 5,576 F2: Represents shares withheld from vested restricted stock units for the payment of federal, state and payroll taxes due on vesting. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 4,587 |
Reported balance
After 2016-11-21 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2016-11-21 · Exercise / conversion · Disposed 1,347 · Balance 4,587 F1: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F3: The restricted stock units vest in three equal installments on November 21, 2014, November 21, 2015, and November 21, 2016. Vested shares will be delivered to the reporting person on vest date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of VAR common stock.
F2: Represents shares withheld from vested restricted stock units for the payment of federal, state and payroll taxes due on vesting.
F3: The restricted stock units vest in three equal installments on November 21, 2014, November 21, 2015, and November 21, 2016. Vested shares will be delivered to the reporting person on vest date.
Varex Imaging Corp
Report date February 14, 2020 · Filed February 19, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 24,434 |
Reported balance
After 2020-02-14 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2020-02-14 · Exercise / conversion · Acquired 2,413 · Balance 24,434 F1: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F2: Amount of securities beneficially owned at end of reporting period reflect 70 shares purchased under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan. |
| Common StockSEC Table I · non-derivative | Direct | 26,254 |
Reported balance
After 2020-02-14 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2020-02-14 · Exercise / conversion · Acquired 1,820 · Balance 26,254 F1: Each Restricted Stock Unit converts into common stock on a one-for-one basis. |
| Common StockSEC Table I · non-derivative | Direct | 28,403 |
Reported balance
After 2020-02-14 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2020-02-14 · Exercise / conversion · Acquired 2,149 · Balance 28,403 F1: Each Restricted Stock Unit converts into common stock on a one-for-one basis. |
| Common StockSEC Table I · non-derivative | Direct | 26,395 |
Reported balance
After 2020-02-14 transaction · row 4
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 4 · 2020-02-14 · Tax withholding · Disposed 2,008 · Balance 26,395 F3: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 2,414 |
Reported balance
After 2020-02-14 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2020-02-14 · Exercise / conversion · Disposed 2,413 · Balance 2,414 F1: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F4: These Restricted Stock Units granted on February 16, 2017 vest 25% each year for four years beginning on February 15, 2018. Vested shares will be delivered to the reporting person upon vest date. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 3,640 |
Reported balance
After 2020-02-14 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2020-02-14 · Exercise / conversion · Disposed 1,820 · Balance 3,640 F1: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F5: These Restricted Stock Units granted on February 15, 2018 vest 25% each year for four years beginning on February 15, 2019. Vested shares will be delivered to the reporting person upon vest date. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 6,447 |
Reported balance
After 2020-02-14 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2020-02-14 · Exercise / conversion · Disposed 2,149 · Balance 6,447 F1: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F6: These Restricted Stock Units granted on February 15, 2019 vest 25% each year for four years beginning on February 15, 2020. Vested shares will be delivered to the reporting person upon vest date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit converts into common stock on a one-for-one basis.
F2: Amount of securities beneficially owned at end of reporting period reflect 70 shares purchased under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan.
F3: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein.
F4: These Restricted Stock Units granted on February 16, 2017 vest 25% each year for four years beginning on February 15, 2018. Vested shares will be delivered to the reporting person upon vest date.
F5: These Restricted Stock Units granted on February 15, 2018 vest 25% each year for four years beginning on February 15, 2019. Vested shares will be delivered to the reporting person upon vest date.
F6: These Restricted Stock Units granted on February 15, 2019 vest 25% each year for four years beginning on February 15, 2020. Vested shares will be delivered to the reporting person upon vest date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 28, 2017 Filed Feb 9, 2017 21:02 UTC Amendment | Varex Imaging Corp VREX · Entity 5135 | GrantRestricted Stock Units · Derivative | 3,618 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-17-000914 · marketforms-37818.xml · derivative · entry 6 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,830 Underlying: Common Stock · 3,618 shares Expires 2019-02-15 F6 · derivative.exercise_price: In connection with the spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F6 · shares: In connection with the spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F8 · derivative.exercise_date: These RSUs vest in two equal annual installments beginning on February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. F8 · derivative.expiration_date: These RSUs vest in two equal annual installments beginning on February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. F6 · derivative.underlying_shares: In connection with the spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F6 · balance_after: In connection with the spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. Read SEC document |
| January 28, 2017 Filed Feb 9, 2017 21:02 UTC Amendment | Varex Imaging Corp VREX · Entity 5135 | GrantRestricted Stock Units · Derivative | 1,601 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-17-000914 · marketforms-37818.xml · derivative · entry 5 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,830 Underlying: Common Stock · 1,601 shares Expires 2018-02-15 F6 · derivative.exercise_price: In connection with the spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F6 · shares: In connection with the spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F7 · derivative.exercise_date: These RSUs vest February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. F7 · derivative.expiration_date: These RSUs vest February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. F6 · derivative.underlying_shares: In connection with the spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F6 · balance_after: In connection with the spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. Read SEC document |
| January 28, 2017 Filed Feb 9, 2017 21:02 UTC Amendment | Varex Imaging Corp VREX · Entity 5135 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 47,786 | $0.00 Strike: $25.17 | $0.00 |
DisclosureSEC source: 0001214659-17-000914 · marketforms-37818.xml · derivative · entry 4 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,786 Underlying: Common Stock · 47,786 shares Expires 2023-02-12 F1 · shares: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. F5 · derivative.exercise_date: Option is subject to a three year vesting schedule, 1/3 of the total number of shares vests in one year from February 12, 2016 and the remaining vests monthly thereafter. F1 · derivative.underlying_shares: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. F1 · balance_after: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. Read SEC document |
| January 28, 2017 Filed Feb 9, 2017 21:02 UTC Amendment | Varex Imaging Corp VREX · Entity 5135 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 27,116 | $0.00 Strike: $30.74 | $0.00 |
DisclosureSEC source: 0001214659-17-000914 · marketforms-37818.xml · derivative · entry 3 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,116 Underlying: Common Stock · 27,116 shares Expires 2022-02-13 F1 · shares: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. F4 · derivative.exercise_date: Option is subject to a three year vesting schedule, 1/3 of the total number of shares vests in one year from February 13, 2015 and the remaining vests monthly thereafter. F1 · derivative.underlying_shares: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. F1 · balance_after: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. Read SEC document |
| January 28, 2017 Filed Feb 9, 2017 21:02 UTC Amendment | Varex Imaging Corp VREX · Entity 5135 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 22,063 | $0.00 Strike: $27.77 | $0.00 |
DisclosureSEC source: 0001214659-17-000914 · marketforms-37818.xml · derivative · entry 2 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,063 Underlying: Common Stock · 22,063 shares Expires 2021-02-21 F1 · shares: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. F3 · derivative.exercise_date: Option is subject to a three year vesting schedule, 1/3 of the total number of shares vests in one year from February 21, 2014 and the remaining vests monthly thereafter. F1 · derivative.underlying_shares: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. F1 · balance_after: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. Read SEC document |
| January 28, 2017 Filed Feb 9, 2017 21:02 UTC Amendment | Varex Imaging Corp VREX · Entity 5135 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 21,047 | $0.00 Strike: $22.84 | $0.00 |
DisclosureSEC source: 0001214659-17-000914 · marketforms-37818.xml · derivative · entry 1 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,047 Underlying: Common Stock · 21,047 shares Expires 2019-11-09 F1 · shares: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. F2 · derivative.exercise_date: Option fully vested three years from grant date. F1 · derivative.underlying_shares: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. F1 · balance_after: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. Read SEC document |
| January 20, 2017 Filed Nov 15, 2017 21:04 UTC | Varex Imaging Corp VREX · Entity 5135 | GrantCommon Stock | 2,230 | $28.15 | $62,774.50 |
DisclosureSEC source: 0001214659-17-006769 · marketforms-40121.xml · nonDerivative · entry 1 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,348 F1 · balance_after: These shares were acquired in connection with the company's separation from Varian Medical Systems, Inc. and were inadvertently omitted from column 5 in the Form 4 dated February 17, 2017. Read SEC document |
| November 21, 2016 Filed Nov 22, 2016 18:48 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionRestricted Stock Units · Derivative | 1,347 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-16-068225 · form4.xml · derivative · entry 3 VERHOEF CLARENCE R · CIK 0001555927 · SVP, Finance, Corp Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,587 Underlying: Common Stock · 1,347 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F3 · derivative.exercise_date: The restricted stock units vest in three equal installments on November 21, 2014, November 21, 2015, and November 21, 2016. Vested shares will be delivered to the reporting person on vest date. F3 · derivative.expiration_date: The restricted stock units vest in three equal installments on November 21, 2014, November 21, 2015, and November 21, 2016. Vested shares will be delivered to the reporting person on vest date. Read SEC document |
| November 21, 2016 Filed Nov 22, 2016 18:48 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Tax withholdingCommon Stock | 474 | $89.66 | $42,498.84 |
DisclosureSEC source: 0001127602-16-068225 · form4.xml · nonDerivative · entry 2 VERHOEF CLARENCE R · CIK 0001555927 · SVP, Finance, Corp Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,576 F2 · shares: Represents shares withheld from vested restricted stock units for the payment of federal, state and payroll taxes due on vesting. Read SEC document |
| November 21, 2016 Filed Nov 22, 2016 18:48 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 1,347 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-16-068225 · form4.xml · nonDerivative · entry 1 VERHOEF CLARENCE R · CIK 0001555927 · SVP, Finance, Corp Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,050 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. Read SEC document |
| November 18, 2016 Filed Nov 21, 2016 19:28 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Tax withholdingCommon Stock | 257 | $88.25 | $22,680.25 |
DisclosureSEC source: 0001127602-16-067962 · form4.xml · nonDerivative · entry 2 VERHOEF CLARENCE R · CIK 0001555927 · SVP, Finance, Corp Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,703 F2 · shares: Represents shares withheld from vested PSUs for the payment of federal, state and payroll taxes due on settlement. F3 · balance_after: Amount of securities beneficially owned at end of reporting period reflect 141 shares purchased on October 28, 2016 under the Varian Medical Systems, Inc. Employee Stock Purchase Plan. Read SEC document |
| November 18, 2016 Filed Nov 21, 2016 19:28 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | GrantCommon Stock | 686 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-16-067962 · form4.xml · nonDerivative · entry 1 VERHOEF CLARENCE R · CIK 0001555927 · SVP, Finance, Corp Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,960 F1 · shares: Represents shares issued upon settlement of performance-based unit award (PSUs) granted November 20, 2013. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.